Weekly Briefing No. 46 | Is ‘New Data’ the Best Hope for Hedge Funds?

Weekly Briefing No. 46 | Is ‘New Data’ the Best Hope for Hedge Funds?

Is ‘New Data’ the answer to hedge funds’ woes? We explore that question as well as Gen Z’s impact on financial institutions and why the SEC should regulate pharmacy benefit managers. Payments news from Facebook and Apple, the rise of usage-based insurance, Ellevest’s financing and John Stumpf’s mea culpa tour hit our radar this week. Finally, we take note of TradeWind Markets and a new career chapter for Citi fintech guru Jorge Ruiz.

Read More